Montelukast 5 mg

Business Unit: Human

Medicine Type: Tablet

Generic Name: Montelukast 5 mg

Therapeutic Class: Leukotriene receptor antagonists

Indication: Monofast is a preparation of Montelukast. Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma. Montelukast is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients from 6 months of age and older.

Dosage & Administration: Adults & adolescents (15 years & older)- Asthma & Allergic Rhinitis: 10 mg/day Exercise-Induced Bronchoconstriction: 10 mg/day Pediatric patients (6 to 14 years)- Asthma & Allergic Rhinitis: 5 mg/day Exercise-Induced Bronchoconstriction: 5 mg/day Pediatric patients (6 months to 5 years)- Asthma & Allergic Rhinitis: 4 mg/day Exercise-Induced Bronchoconstriction: Not recommended Patients with both asthma and allergic rhinitis should take only one dose daily in the evening. For prevention of Acute prevention of Exercise-Induced Bronchoconstriction, a single dose should be taken at least 2 hours before exercise. Route of administration: Oral. Montelukast may be taken with or without food or as directed by the physician.

Preparation: 10x3 Tablets